CVS Health reported earnings that beat Wall Street’s expectations and upgraded its projection for 2025, as its health-insurance business showed signs of recovery
CVS Health just posted better-than-expected earnings and raised its 2025 outlook, thanks in part to a rebound in its health insurance division. While some insurers are still struggling, CVS seems to be turning a corner—for now.
Editor’s Note: This isn’t just another earnings report—it’s a sign that CVS might be stabilizing after a rocky stretch. With healthcare costs still a hot-button issue, a stronger CVS could mean more stability for patients and investors alike. But the split in the insurance market shows not everyone’s out of the woods yet.
Claire Eady is advocating for stricter regulations for older drivers after her elderly mother died in a car crash. She believes updated rules could have prevented the tragedy.
Editor’s Note: This story highlights the ongoing debate about driver safety, particularly for older individuals, and how policy changes might prevent future accidents. It’s a personal yet impactful call to action that could resonate with families and lawmakers alike.
The Department of Veterans Affairs (VA) has been prescribing a risky combination of powerful drugs—dubbed the "Combat Cocktail"—to treat veterans with PTSD, despite concerns from both patients and doctors. Many veterans say they don’t want this treatment, and medical professionals warn it increases suicide risk. Yet, hundreds of thousands continue to receive it.
Editor’s Note: This story highlights a troubling gap between medical practice and patient well-being in the VA system. Veterans struggling with PTSD are being given drugs that could make their condition worse, raising serious ethical and safety questions. It’s a stark reminder of how systemic failures can harm those who’ve already sacrificed so much.
Scientists have developed a groundbreaking implant designed to alleviate the chronic pain and inflammation caused by rheumatoid arthritis. Unlike traditional treatments that rely on frequent injections or oral meds, this tiny device works by delivering targeted therapy directly to affected joints, potentially reducing side effects and improving quality of life for millions. Early trials show promise, though larger studies are needed before it becomes widely available.
A local moms' support group in Omagh called Support 2gether is celebrating after being named a finalist in the BBC's Make a Difference Awards. The group, which helps mothers connect and share resources, is described as "buzzing" with excitement over the recognition.
Editor’s Note: This story highlights the impact of grassroots organizations that bring people together. Being recognized by a major platform like the BBC not only validates their hard work but also shines a light on the importance of community support networks—especially for parents who often juggle multiple challenges. It’s a feel-good reminder that small efforts can lead to big recognition.
Former President Trump is pushing pharmaceutical companies to lower certain drug prices in the U.S. by September, though his administration hasn't clarified how it would legally enforce such a demand.
Editor’s Note: This story matters because high drug prices are a major concern for Americans, and any move to address them—even if it's unclear how it would work—could impact millions of people. However, without a clear legal pathway, it's uncertain whether this demand will lead to real changes or just remain political rhetoric.